State Rep. Bob Rita had famously testified in the 2023 “ComEd Four” trial that his former boss Madigan ruled the House ...

With allegations of corruption at the highest levels of state government, the racketeering trial of former Democratic House ...

Sangamo (SGMO) announced updated data from the Phase 1/2 STAAR study evaluating isaralgagene civaparvovec, or ST-920, a wholly owned gene therapy product candidate for the treatment of Fabry ...

RICHMOND, Calif. - Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company with a market capitalization of $263 million, has announced promising updated results from its Phase 1/2 ...

Sangamo Therapeutics (NASDAQ:SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate isaralgagene civaparvovec, or ST-920, in the treatment of Fabry disease. The ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report). The company’s shares closed yesterday at $1.27. Leverage the power ...

Now Gilead is spending a further $150 million upfront to access the cutting edge gene-editing technology of another Californian biotech, Sangamo. The ambition for this cancer-focused collaboration ...

RICHMOND, Calif., December 30, 2024--SANGAMO THERAPEUTICS TO REGAIN FULL RIGHTS TO HEMOPHILIA A GENE THERAPY PROGRAM FOLLOWING PFIZER’S DECISION TO CEASE DEVELOPMENT Astellas Pharma Inc. (TSE ...

Why the future remains bright for Riverton boys basketball despite 0-3 Sangamo start Results can be emailed to [email protected]. Griffin McClure went 8-for-11 from the floor and scored a game-high ...

Personalized medicine advances as autologous cell therapy grows, leveraging refined cell collection, improved processing ...

From the killer-budget phones to the ultra-flagships, there is a phone for everyone. Of course, the market always has a few clear frontrunners, and if you're interested in the phones that were the ...